NCT02535091: A trial that was reported late by SK Life Science, Inc.
This trial has reported, although it was 684 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02535091 |
|---|---|
| Title | An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Aug. 3, 2016 |
| Completion date | March 31, 2021 |
| Required reporting date | March 31, 2022, midnight |
| Actual reporting date | Feb. 13, 2024 |
| Date last checked at ClinicalTrials.gov | May 15, 2026 |
| Days late | 684 |